Infectious Disease Rapid Diagnostic Testing for HPV Market Research Report - Segmentation by Product & Service (Reagents & Kits, Instruments, Data Management Software, Service); Technology (Clinical Microbiology, DNA Microassay, Immunoassay, Isothermal Nucleic Acid Amplification Technology (INAAT), Polymerize Chain Reaction (PCR), Others); End User (Academic & Research Institutes, Diagnostic Centers, Hospitals & Clinical Laboratories, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15162
Format:
Region: Global
Chapter 1. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING FOR HPV MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING FOR HPV MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-110 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING FOR HPV MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING FOR HPV MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING FOR HPV MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING FOR HPV MARKET – By Product & Service
6.1 Reagents & Kits
6.2. Instruments
6.3. Data Management Software
6.4. Service
Chapter 7. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING FOR HPV MARKET– By Technology
7.1. Clinical Microbiology
7.2. DNA Microassay
7.3. Immunoassay
7.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5. Polymerize Chain Reaction (PCR)
7.6. Others
Chapter 8. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING FOR HPV MARKET - By Application
8.1. Academic & Research Institutions
8.2. Diagnostic Centers
8.3. Hospitals & Clinical Laboratories
8.4. Others
Chapter 9. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING FOR HPV MARKET – By Region
9.1. North America
9.2. Europe
9.3.The Asia Pacific
9.4.Latin America
9.5. Middle-East and Africa
Chapter 10. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING FOR HPV MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1. QIAGEN (Germany)
10.2. Abbott Laboratories (United States)
10.3. Becton, Dickinson, and Company (United States)
10.4. Fast Track Diagnostics (Luxembourg)
10.5. Thermo Fisher Scientific Inc. (United States)
10.6. Bio-Rad Laboratories, Inc. (United States)
10.7. Cepheid Inc. (United States)
10.8. Roche Holding AG (Switzerland)
10.9. Hologic, Inc. (United States)
10.10. GenMark Diagnostics, Inc. (United States)
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
Global Infectious Disease Rapid Diagnostic Testing for HPV Market is estimated to be worth USD 2.78 Billion in 2022 and is projected to reach a value of USD 4.78 Billion by 2030, growing at a CAGR of 7.0% during the forecast period 2023-2030.
The Global Infectious Disease Rapid Diagnostic Testing for HPV Market Drivers is the rising incidence of HPV-related disease and the increasing demand for novel and effective diagnostic techniques.
Based on the Product and Service, the Global Infectious Disease Rapid Diagnostic Testing for HPV market is segmented into Reagents and Kits, Instruments, Data Management Software, and Service.
The United States is the most dominating country in the region of North America for the Global Infectious Disease Rapid Diagnostic Testing for HPV Market
QIAGEN, Abbott Laboratories, and Becton, Dickinson, and Company are the leading players in the Global Infectious Disease Rapid Diagnostic Testing for HPV Market.
